WebJul 7, 2014 · Oncologists at the University of Chicago have developed a tool to measure patients’ risk for financial toxicity following cancer diagnosis and treatment. The 11-part Comprehensive Score for Financial Toxicity (COST) assesses a patient’s risk for financial distress due to the high cost of treatment and subsequent economic challenges, such as ... WebOct 28, 2024 · Objective Using the Comprehensive Score for Financial Toxicity (COST) tool to measure financial toxicity (FT) among nasopharyngeal cancer (NPC) patients in western China and investigate …
Measurement and Validation of the Comprehensive Score for Financial …
WebOverview. Developed in conjunction with the University of Chicago, the COST is a patient-reported outcome measure that describes the financial distress experienced by cancer patients. Since its initial publication, an additional item from the FACIT System has been … WebFeb 1, 2024 · The COST measure demonstrated reliability and validity in measuring financial toxicity. Its correlation with HRQOL indicates that financial toxicity is a … rega planar 3 wow and flutter
COST: A New Tool to Measure Financial Toxicity as a PRO
WebFeb 10, 2024 · The FACT COST is a patient‐rated measure of financial toxicity, developed and validated in a North American population. We aimed to confirm the validity and … WebOct 1, 2024 · Although the burden of cancer costs on the US healthcare system is well-recognized, 1,2 more recently, the personal “financial toxicity” associated with the cost of care has also been identified as a distinct consequence of cancer treatment. 3–13 A recent systematic review that sought to define the prevalence of the types of financial ... Webfor financial Toxicity (COST) measure. The authors collected data regarding patient characteristics, clinical trial participation, health care use, willingness to discuss costs, psychological distress (Brief Profile of Mood States [POMS]), and … rega p3 white